|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 50, S335-S339, April 2009
Diabetes and atherosclerosis: is there a role for hyperglycemia?
* Departments of Medicine and Diabetes and Obesity Center of Excellence, University of Washington School of Medicine, Seattle, WA 98109 Research in the authors' laboratories is funded by National Institutes of Health grants HL30086, HL92969, and HL18645 to A.C.; and HL62887, HL92969, and 5-2008-257 from the Juvenile Diabetes Research Foundation to K.E.B. Published, JLR Papers in Press, November 23, 2008.
1 To whom correspondence should be addressed. e-mail: achait{at}u.washington.edu
Atherosclerosis is accelerated in both type 1 and type 2 diabetes. The hallmark of diabetes is the presence of hyperglycemia. In this article, we review the role of glucose in the pathogenesis of atherosclerosis. Evidence obtained from epidemiological, in vitro, and animal studies will be reviewed in an attempt to understand the complex relationship between hyperglycemia and cardiovascular risk that is emerging from clinical trials.
Supplementary key words glycemic control lesion initiation lesion progression dyslipidemia cardiovascular risk epidemiology animal studies
Related Webpages:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||